104 related articles for article (PubMed ID: 12213409)
1. Synergistic adjuvant activity of immunostimulatory DNA and oil/water emulsions for immunization with HIV p55 gag antigen.
O'Hagan DT; Singh M; Kazzaz J; Ugozzoli M; Briones M; Donnelly J; Ott G
Vaccine; 2002 Sep; 20(27-28):3389-98. PubMed ID: 12213409
[TBL] [Abstract][Full Text] [Related]
2. Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1.
O'Hagan DT; Ugozzoli M; Barackman J; Singh M; Kazzaz J; Higgins K; Vancott TC; Ott G
Vaccine; 2000 Mar; 18(17):1793-801. PubMed ID: 10699327
[TBL] [Abstract][Full Text] [Related]
3. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E
Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.
Kojima Y; Xin KQ; Ooki T; Hamajima K; Oikawa T; Shinoda K; Ozaki T; Hoshino Y; Jounai N; Nakazawa M; Klinman D; Okuda K
Vaccine; 2002 Jul; 20(23-24):2857-65. PubMed ID: 12126895
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of HIV-1 subtype C vaccine constructs induced immune response in mice by CpG motif 1826-ODN.
Aggarwal P; Pandey RM; Seth P
Viral Immunol; 2005; 18(1):213-23. PubMed ID: 15802966
[TBL] [Abstract][Full Text] [Related]
6. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.
Denis-Mize KS; Dupuis M; MacKichan ML; Singh M; Doe B; O'Hagan D; Ulmer JB; Donnelly JJ; McDonald DM; Ott G
Gene Ther; 2000 Dec; 7(24):2105-12. PubMed ID: 11223992
[TBL] [Abstract][Full Text] [Related]
7. Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.
Singh M; Ott G; Kazzaz J; Ugozzoli M; Briones M; Donnelly J; O'Hagan DT
Pharm Res; 2001 Oct; 18(10):1476-9. PubMed ID: 11697476
[No Abstract] [Full Text] [Related]
8. Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity.
Singh M; Vajdy M; Gardner J; Briones M; O'Hagan D
Vaccine; 2001 Nov; 20(3-4):594-602. PubMed ID: 11672926
[TBL] [Abstract][Full Text] [Related]
9. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
Fuller DH; Haynes JR
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
[TBL] [Abstract][Full Text] [Related]
10. Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.
Tritel M; Stoddard AM; Flynn BJ; Darrah PA; Wu CY; Wille U; Shah JA; Huang Y; Xu L; Betts MR; Nabel GJ; Seder RA
J Immunol; 2003 Sep; 171(5):2538-47. PubMed ID: 12928404
[TBL] [Abstract][Full Text] [Related]
11. The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery.
Briones M; Singh M; Ugozzoli M; Kazzaz J; Klakamp S; Ott G; O'Hagan D
Pharm Res; 2001 May; 18(5):709-12. PubMed ID: 11465430
[No Abstract] [Full Text] [Related]
12. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of HIV type 1 vaccine immunogenicity by block copolymer adjuvants. I. Induction of high-titer, long-lasting, cross-reactive antibodies of broad isotype.
McNicholl JM; Bond KB; Ruhadze ER; Olsen MR; Takayama K; Hunter RL
AIDS Res Hum Retroviruses; 1998 Nov; 14(16):1457-71. PubMed ID: 9824324
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
Jiang JQ; Patrick A; Moss RB; Rosenthal KL
J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
[TBL] [Abstract][Full Text] [Related]
15. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.
Manocha M; Pal PC; Chitralekha KT; Thomas BE; Tripathi V; Gupta SD; Paranjape R; Kulkarni S; Rao DN
Vaccine; 2005 Dec; 23(48-49):5599-617. PubMed ID: 16099080
[TBL] [Abstract][Full Text] [Related]
16. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.
zur Megede J; Chen MC; Doe B; Schaefer M; Greer CE; Selby M; Otten GR; Barnett SW
J Virol; 2000 Mar; 74(6):2628-35. PubMed ID: 10684277
[TBL] [Abstract][Full Text] [Related]
17. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.
Moore A; McGuirk P; Adams S; Jones WC; McGee JP; O'Hagan DT; Mills KH
Vaccine; 1995 Dec; 13(18):1741-9. PubMed ID: 8701587
[TBL] [Abstract][Full Text] [Related]
18. Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen.
Richards RL; Rao M; Vancott TC; Matyas GR; Birx DL; Alving CR
Immunol Cell Biol; 2004 Oct; 82(5):531-8. PubMed ID: 15479439
[TBL] [Abstract][Full Text] [Related]
19. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120.
Jankovic D; Caspar P; Zweig M; Garcia-Moll M; Showalter SD; Vogel FR; Sher A
J Immunol; 1997 Sep; 159(5):2409-17. PubMed ID: 9278332
[TBL] [Abstract][Full Text] [Related]
20. Potent antigen-specific immune responses stimulated by codelivery of CpG ODN and antigens in degradable microparticles.
Zhang XQ; Dahle CE; Baman NK; Rich N; Weiner GJ; Salem AK
J Immunother; 2007; 30(5):469-78. PubMed ID: 17589287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
